Serum Institute's CEO Expects To Launch Novavax Vaccine For Kids In Six Months: Reuters

The Serum Institute of India (SII) plans to launch the Novavax Inc NVAX COVID-19 vaccine for children in India in six months, Adar Poonawalla said.
The Novavax shot, called Covovax, has shown promising results in trials in three and older children, Adar Poonawalla told a virtual conference organized by the Confederation of Indian Industry.
"Our vaccine will be launched in six months," he said. "It is under trial and has shown excellent data down to the age group of 3."
Yesterday, Novavax submitted a regulatory filing to the Ministry of Health and Prevention (MoHaP) for emergency use of its COVID-19 vaccine in the United Arab Emirates.
Related Link: Novavax Shares Jump After Head Of EU Drug Regulator Hints At Imminent Authorization For COVID-19 Vaccine.
Price Action: NVAX shares are up 1.15% at $171 during the premarket session on the last check Tuesday.